Prat, A, Di Muro, MA, Acosta, SF, Vazquez, T, Rosell, SB, Orellana, R, Fumagalli, C. NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).

Carrillo-García, J, Hindi, N, Conceicao, M, Sala, MA, Ugalde, A, López-Pousa, A, Bagué, S, Sevilla, I, Vicioso, L, Ramos, R, Martínez-Trufero, J, Mateo, MCG, Cruz, J, Hernández-León, CN, Redondo, A, Mendiola, M, García, JM, Hernández, JE, Alvarez, R, Agra, C, de Juan-Ferré, A, Valverde, C, Cano, JM, de Sande, LM, Pérez-Fidalgo, JA, Lavernia, J, Marcilla, D, Gutiérrez, A, Moura, DS, Martín-Broto, J. Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor. EUROPEAN JOURNAL OF CANCER. 2024; 209DOI:10.1016/j.ejca.2024.114270. PMID:39142211. IF:7.100(Q1/2D).

Pasquali, S, Vallacchi, V, Lalli, L, Collini, P, Barisella, M, Romagosa, C, Bague, S, Coindre, JM, Dei Tos, AP, Palmerini, E, Quagliuolo, V, Martin-Broto, J, Lopez-Pousa, A, Grignani, G, Blay, JY, Beveridge, RD, Casiraghi, E, Brich, S, Renne, SL, Bergamaschi, L, Vergani, B, Sbaraglia, M, Casali, PG, Rivoltini, L, Stacchiotti, S, Gronchi, A. Spatial distribution of tumour immune in fi ltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy. EBioMedicine. 2024; 106DOI:10.1016/j.ebiom.2024.105220. PMID:39018755. IF:10.800(Q1/1D).

Espinosa, I, D'Angelo, E, Prat, J. Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging. GYNECOLOGIC ONCOLOGY. 2024; 186DOI:10.1016/j.ygyno.2024.04.008. PMID:38615479. IF:4.100(Q1/1D).

Virgili, AC, Salazar, J, Gallardo, A, López-Pousa, A, Terés, R, Bagué, S, Orellana, R, Fumagalli, C, Mangues, R, Alba-Castellón, L, Unzueta, U, Casanova, I, Sebio, A. CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics. 2024; 14(11)DOI:10.3390/diagnostics14111195. PMID:38893721. IF:3.300(Q1/2D).

Cullell, BM, Manrique, ACV, Piedra, A, Fumagalli, C, Mateo, FJP, Serda, PC, Mirallas, O, Martínez, E, Trujillo, JC, Belda-Sanchis, J, Szafranska, J, Paez, D. Immune phenotypes and histological growth patterns in resected lung metastasis of colorectal cancer patients to assess prognosis. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.133. PMID:. IF:65.400(Q1/1D).

Conde, E, Hernandez, S, Carrillo, JLR, Martinez, R, Alonso, M, Curto, D, Jimenez, B, Caminoa, A, Benito, A, Garrido, P, Clave, S, Arriola, E, Esteban-Rodriguez, I, De Castro, J, Sansano, I, Felip, E, Rojo, F, Dómine, M, Abdulkader, I, Garcia-Gonzalez, J, Teixido, C, Reguart, N, Compañ, D, Insa, A, Mancheño, N, Palanca, S, Juan-Vidal, O, Baixeras, N, Nadal, E, Cebollero, M, Calles, A, Martin, P, Salas, C, Provencio, M, Aranda, I, Massuti, B, Lopez-Vilaro, L, Majem, M, Paz-Ares, L, Lopez-Rios, F. RET Fusion Testing in Patients With NSCLC: The RETING Study. Jto Clinical And Research Reports. 2024; 5(4)DOI:10.1016/j.jtocrr.2024.100653. PMID:38525319. IF:(Q/D).

Gronchi, A, Palmerini, E, Quagliuolo, V, Broto, JM, Pousa, AL, Grignani, G, Brunello, A, Blay, JY, Tendero, O, Beveridge, RD, Ferraresi, V, Lugowska, I, Pizzamiglio, S, Verderio, P, Fontana, V, Donati, DM, Palassini, E, Sanfilippo, R, Bianchi, G, Bertuzzi, A, Morosi, C, Pasquali, S, Stacchiotti, S, Bagué, S, Coindre, JM, Miceli, R, Dei Tos, AP, Casali, PG. Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG). JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(8)DOI:10.1200/JCO.23.00908. PMID:38232337. IF:41.900(Q1/1D).